Hospital Frailty Risk score

There are 331 papers on Hospital Frailty Risk score in aging research: 2 trials and 302 observational studies in people, 25 reviews. The newest story, Nov 12, 2026: “Frailty alters link between blood-flow procedures and amputation”.

Biomarker

331 papers study it35 more mention it345 findings

18 new papers in 30 daysSee all 366 papers on Hospital Frailty Risk score

“HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0·020).”
Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2The lancet. Healthy longevity2026doi:10.1016/j.lanhl.2026.100894
  • Human trial2
  • Humans302
  • In silico1

Interventions

1

COVID-19 pandemic

downin humans1

1 study
  1. COVID-19 pandemic is linked with lower Hospital Frailty Risk score in humans (hospitalized brain tumor patients) (3.1 to 2.6, p < 0.01).

    Humanshospitalized brain tumor patients

More on COVID-19 pandemic

Effects

30

Mortality

no changein humans6upin humans1HR 1.17

7 studies
  1. Hospital Frailty Risk score was not clearly linked with mortality in humans After atrial fibrillation ablation; adjusted for age and sex (aHR 1.09, 95% CI 0.95–1.21; p=0.292).

    HumansAfter atrial fibrillation ablation; adjusted for age and sexMedian follow-up 4.4 years57% malesn = 2,865

  2. Hospital Frailty Risk score was not clearly linked with mortality in humans (acute coronary syndrome).

    Humansacute coronary syndromeoriginal cut-off9 monthsn = 504

  3. Hospital Frailty Risk score is linked with higher mortality in humans following elective primary TEA (1.7% vs. 0.2%).

    Humansfollowing elective primary TEA

  4. Hospital Frailty Risk score was not clearly linked with mortality in humans (AUC 0.506 (CI 0.502-0.511)).

    Humans30 daysn = 167,316

  5. Hospital Frailty Risk score was not clearly linked with mortality in humans (hip fracture).

    Humanship fracturen = 1,014

  6. Hospital Frailty Risk score was not clearly linked with mortality in humans (due to low number of deaths in the study group).

    Humansdue to low number of deaths in the study group

  7. Hospital Frailty Risk score was not clearly linked with mortality in Swedish cohort (HR = 1.17, 95% CI 0.92, 1.49).

    Humansin Swedish cohort36 yearsn = 1,368

Length of stay

upin humans7OR 2.38

7 studies
  1. Hospital Frailty Risk score is linked with higher length of stay in adult hospital patients (P < 0.001).

    Humansin adult hospital patients

  2. Hospital Frailty Risk score is linked with higher length of stay in humans (MD 4.26, 95% CI 4.19-4.34, p < 0.001).

    Humansn = 885,416

  3. Hospital Frailty Risk score is linked with higher length of stay in humans (aneurysmal subarachnoid hemorrhage undergoing neurosurgical procedures) (coefficient 8.4, 95% CI: 5.1-11.7).

    Humansaneurysmal subarachnoid hemorrhage undergoing neurosurgical proceduresn = 1,343

  4. Hospital Frailty Risk score is linked with higher length of stay in humans (head and neck procedures) (9 days compared to 3).

    Humanshead and neck procedures

  5. Hospital Frailty Risk score is linked with higher length of stay in hospitalized patients with chronic pancreatitis (7.04 days, 95% CI 6.57-7.52).

    Humansin hospitalized patients with chronic pancreatitis

  6. Hospital Frailty Risk score is linked with higher length of stay in humans (hip fracture) (14 vs 10 vs 8 days).

    Humanship fracturen = 1,014

  7. Hospital Frailty Risk score is linked with higher length of stay in humans after endovascular treatment of ruptured intracranial aneurysms (intermediate: OR 2.38, p<0.001; high: OR 4.49, p<0.001).

    Humansafter endovascular treatment of ruptured intracranial aneurysms

Hospital length of stay

upin humans2

2 studies
  1. Hospital Frailty Risk score is linked with higher hospital length of stay in humans following elective primary TEA (5.3 days vs. 2.6 days).

    Humansfollowing elective primary TEA

  2. Hospital Frailty Risk score is linked with higher hospital length of stay in humans (intracranial tumor resection) (coefficient = 0.50, p < 0.0001).

    Humansintracranial tumor resectionn = 2,518

Mortality discrimination

upin humans1

1 study
  1. Hospital Frailty Risk score is linked with better mortality discrimination in humans (Addition of HFRS to the clinical survival model in hepatocellular carcinoma) (Harrell’s C-statistic 0.731 to 0.742; Δ 0.011, 95% CI 0.004–0.019).

    HumansAddition of HFRS to the clinical survival model in hepatocellular carcinoman = 1,397

Ischemic stroke or transient ischemic attack admission

no changein humans1HR 1.05

1 study
  1. Hospital Frailty Risk score was not clearly linked with ischemic stroke or transient ischemic attack admission in humans (Adjusted subdistribution HR 1.05, 95% CI 0.81–1.37; p=0.700).

    HumansAfter atrial fibrillation ablation; adjusted for age and sex with death as a competing riskMedian follow-up 4.4 years57% malesn = 2,865

Heart failure admission

no changein humans1HR 0.98

1 study
  1. Hospital Frailty Risk score was not clearly linked with heart failure admission in humans (Adjusted subdistribution HR 0.98, 95% CI 0.82–1.17; p=0.840).

    HumansAfter atrial fibrillation ablation; adjusted for age and sex with death as a competing riskMedian follow-up 4.4 years57% malesn = 2,865

Inpatient mortality

no changein humans1

1 study
  1. Hospital Frailty Risk score was not clearly linked with inpatient mortality in humans (ischemic stroke).

    Humansischemic stroken = 1,023

Hospital readmission

no changein humans1

1 study
  1. Hospital Frailty Risk score was not clearly linked with hospital readmission in humans (ischemic stroke).

    Humansischemic stroken = 1,023

NIH Stroke Scale

no changein humans1

1 study
  1. Hospital Frailty Risk score was not clearly linked with NIH Stroke Scale in humans (ischemic stroke undergoing endovascular treatment) (14 vs 15 vs 15; p = 0.295).

    Humansischemic stroke undergoing endovascular treatmentn = 2,468

More on NIH Stroke Scale

Functional outcome

downin humans1OR 0.962

1 study
  1. Hospital Frailty Risk score is linked with worse functional outcome in humans (ischemic stroke undergoing endovascular treatment) (adjusted OR: 0.962, 95% CI: 0.929-0.997; p = 0.033).

    Humansischemic stroke undergoing endovascular treatment3 monthsn = 2,468

All 30

Upstream

2

Brain tumor care

downin humans1

1 study
  1. brain tumor care is linked with lower Hospital Frailty Risk score in humans (trends from pre-pandemic to pandemic phase) (2.1 to 1.6, p < 0.01).

    Humanstrends from pre-pandemic to pandemic phasen = 20,005

COVID-19

no changein humans1OR 1.05

1 study
  1. COVID-19 was not clearly linked with Hospital Frailty Risk score in humans (geriatric patients readmitted three months after initial admission) (OR 1.05, 95% CI 0.87-1.26).

    Humansgeriatric patients readmitted three months after initial admission

More on COVID-19

Associations

145

Mortality

upin humans49downin humans2no changein humans2HR 0.47–3.79

53 studies
  1. Hospital Frailty Risk score is associated with mortality in humans (Hepatocellular carcinoma; elevated versus low HFRS) (Median overall survival 21.3 vs. 35.4 months; adjusted HR 1.54, 95% CI 1.32–1.80).

    HumansHepatocellular carcinoma; elevated versus low HFRSn = 1,397

  2. Hospital Frailty Risk score is linked with a higher risk of mortality in elective hospitalizations with non-cardiac surgery (22.8-fold).

    Humansin elective hospitalizations with non-cardiac surgery

    Frailty tracks surgical risk while arthritis adds discharge needs

    Arthritis care & research
  3. Hospital Frailty Risk score is associated with mortality in humans (VA ECMO patients, low HFRS (<=10) versus high (>10)) (HR=0.47, 95% CI 0.26-0.87, p=0.017).

    HumansVA ECMO patients, low HFRS (<=10) versus high (>10)90 daysn = 180

  4. Hospital Frailty Risk score is linked with a higher risk of mortality in humans (undergoing non-cardiac surgery) (OR 1.53, 95% CI 1.49-1.58).

    Humansundergoing non-cardiac surgery30-day

  5. Hospital Frailty Risk score is associated with mortality in humans (ischemic stroke).

    Humansischemic stroken = 1,023

  6. Hospital Frailty Risk score is associated with mortality in humans (critically ill patients with sepsis (frail status)) (RR = 1.29, 95% CI: [1.17, 1.42]).

    Humanscritically ill patients with sepsis (frail status)n = 10,591

  7. Hospital Frailty Risk score predicts mortality in humans (compared with reference group (no risk)) (OR 50.92, 95% CI 2.92–887.08, p < 0.01).

    Humanscompared with reference group (no risk)n = 814

  8. Hospital Frailty Risk score is linked with a higher risk of mortality in humans (Hospital Frailty Risk Score > 15, following GI cancer resection) (aOR 2.04).

    HumansHospital Frailty Risk Score > 15, following GI cancer resection90-dayn = 21,729

  9. Hospital Frailty Risk score is associated with mortality in humans (fully adjusted model in hospitalized HCC patients) (15% increased odds (95% CI: 1.14, 1.16)).

    Humansfully adjusted model in hospitalized HCC patients

  10. Hospital Frailty Risk score is associated with mortality in humans (HR 1.16, 95% CI: 0.88-1.54).

    Humans1 year

All 53

In-hospital mortality

upin humans25downin humans2upin silico1OR 1.1–11.2

28 studies
  1. Hospital Frailty Risk score is associated with in-hospital mortality in humans (Cardiogenic shock treated with VA-ECMO; HFRS ≥5 versus <5) (49.3% vs 45.6%; adjusted OR 1.25, 95% CI 1.10–1.43; p=0.001).

    HumansCardiogenic shock treated with VA-ECMO; HFRS ≥5 versus <5During hospitalizationn = 34,260

    Higher frailty linked to hospital deaths on heart-lung support

    AHA Scientific Sessions 2026 abstract
  2. Hospital Frailty Risk score is associated with in-hospital mortality in humans (acute pulmonary embolism; high versus low HFRS) (aOR 8.30, 95% CI 7.24–9.52).

    Humansacute pulmonary embolism; high versus low HFRSduring hospitalizationn = 220,455

  3. Hospital Frailty Risk score predicts in-hospital mortality in humans (hospitalized with community-acquired pneumonia) (mean |SHAP| = 0.66).

    Humanshospitalized with community-acquired pneumonian = 58,306

  4. Hospital Frailty Risk score is associated with in-hospital mortality in humans (metastatic colorectal cancer) (OR = 1.10, 95% CI 1.05-1.17).

    Humansmetastatic colorectal cancer

  5. Hospital Frailty Risk score is associated with in-hospital mortality in humans (Acute pulmonary embolism; reduced Firth model) (OR 11.2; 95% CI: 1.976–63.964).

    HumansAcute pulmonary embolism; reduced Firth modelIn-hospitaln = 237

  6. Hospital Frailty Risk score is linked with a higher risk of in-hospital mortality in adult hospital patients (P < 0.001).

    Humansin adult hospital patients

  7. Hospital Frailty Risk score is associated with in-hospital mortality in humans (community-acquired pneumonia) (HR = 1.57, 95% CI: 1.47-1.68).

    Humanscommunity-acquired pneumonian = 58,040

  8. Hospital Frailty Risk score is linked with a higher risk of in-hospital mortality in humans (intermediate risk: OR 9.61, 95% CI: 8.96-10.30; high risk: OR 24.58, 95% CI: 21.55-28.04).

    Humans

  9. Hospital Frailty Risk score is associated with in-hospital mortality in humans (high frailty risk vs zero frailty risk) (+2.3% probability of dying (95% CI 1.99-2.61)).

    Humanshigh frailty risk vs zero frailty risk

  10. Hospital Frailty Risk score predicts in-hospital mortality in humans (OR 9.51, 95% CI 3.49-26.00).

    Humansundergoing percutaneous coronary intervention for chronic total occlusion, compared to low-risk groupn = 46,695

All 30

Length of stay

upin humans15OR 7.33

15 studies
  1. Hospital Frailty Risk score is associated with length of stay in humans (ischemic stroke).

    Humansischemic stroken = 1,023

  2. Hospital Frailty Risk score is associated with length of stay in humans (critically ill patients with sepsis).

    Humanscritically ill patients with sepsisn = 10,591

  3. Hospital Frailty Risk score is associated with length of stay in humans (emergency hospital admission).

    Humansemergency hospital admission

  4. Hospital Frailty Risk score predicts length of stay in humans (hospitalized) (1.92 times higher (95% CI 1.79-2.06)).

    Humanshospitalizedn = 34,731

  5. Hospital Frailty Risk score predicts length of stay in humans (heart failure hospitalizations) (4.24 vs 7.18 vs 12.1 days).

    Humansheart failure hospitalizations

  6. Hospital Frailty Risk score predicts length of stay in hospitalized kidney transplant recipients.

    Humansin hospitalized kidney transplant recipientsn = 185,742

  7. Hospital Frailty Risk score predicts length of stay in humans (hospitalized patients) (AUROCs ranging from 0·867 to 0·890).

    Humanshospitalized patients

  8. Hospital Frailty Risk score is associated with length of stay in humans (hospitalized patients) (AUROCs ranging from 0·867 to 0·890).

    Humanshospitalized patients

  9. Hospital Frailty Risk score is associated with length of stay in patients with primary pulmonary hypertension (6 days vs. 11 days vs. 19 days, p < 0.001).

    Humansin patients with primary pulmonary hypertensionn = 4,555

  10. Hospital Frailty Risk score is associated with length of stay in humans (meningioma resection) (p < 0.0001).

    Humansmeningioma resectionn = 464

All 16

Postoperative complications

upin humans7OR 1.05–1.14

7 studies
  1. Hospital Frailty Risk score is linked with a higher risk of postoperative complications in humans (undergoing simultaneous CRC/CRLM resections) (aOR = 3.47, 95% CI: 3.03, 3.97).

    Humansundergoing simultaneous CRC/CRLM resectionsn = 4,514

  2. Hospital Frailty Risk score is linked with a higher risk of postoperative complications in humans (chronic mesenteric ischemia revascularization, high frailty risk vs low risk) (aOR 8.74).

    Humanschronic mesenteric ischemia revascularization, high frailty risk vs low riskfemale: 71%sn = 4,100

  3. Hospital Frailty Risk score predicts postoperative complications in humans (P < .001).

    Humans180 days

  4. Hospital Frailty Risk score predicts postoperative complications in humans (meningioma resection) (OR = 1.05, p = 0.019).

    Humansmeningioma resectionn = 464

  5. Hospital Frailty Risk score is linked with a higher risk of postoperative complications in humans (intracranial tumor resection) (OR 1.14, p < 0.0001).

    Humansintracranial tumor resectionn = 2,518

  6. Hospital Frailty Risk score predicts postoperative complications in humans (patients diagnosed with craniopharyngioma undergoing surgery) (100% vs 76% vs 63%).

    Humanspatients diagnosed with craniopharyngioma undergoing surgery

  7. Hospital Frailty Risk score is associated with postoperative complications in humans (patients undergoing spine surgery for metastatic spinal column tumors) (low frailty: 29.2%; intermediate frailty: 53.8%; high frailty: 76.6%; p < 0.001).

    Humanspatients undergoing spine surgery for metastatic spinal column tumorsn = 11,480

Hospital readmission

upin humans6+10% higher riskOR 1.8–2.4

6 studies
  1. Hospital Frailty Risk score is associated with hospital readmission in humans (older patients with diagnosis of dementia and/or cognitive impairment) (aOR 2.178, 95% CI: 1.756-2.702; p < 0.001).

    Humansolder patients with diagnosis of dementia and/or cognitive impairmentn = 3,090

  2. Hospital Frailty Risk score predicts hospital readmission in humans (P < .001).

    Humans180 days

  3. Hospital Frailty Risk score is linked with a higher risk of hospital readmission in humans (OR 2.40, 95% CI: 2.19, 2.63).

    Humansn = 21,976

  4. Hospital Frailty Risk score is linked with a higher risk of hospital readmission in humans (hospitalized adults with systemic lupus erythematosus) (10% higher risk).

    Humanshospitalized adults with systemic lupus erythematosuseight monthsn = 39,738

  5. Hospital Frailty Risk score is associated with hospital readmission in humans (head and neck procedures) (27%).

    Humanshead and neck procedures

  6. Hospital Frailty Risk score is linked with a higher risk of hospital readmission in humans (OR 1.80, 95% CI 1.58-2.05).

    Humansafter percutaneous LAAC, HFRS >15 compared with HFRS <5, adjusted for age, sex, comorbidities

30-day mortality

upin humans6OR 2.16–4.15

6 studies
  1. Hospital Frailty Risk score predicts 30-day mortality in humans (solid tumor).

    Humanssolid tumorn = 587

  2. Hospital Frailty Risk score predicts 30-day mortality in humans (emergency bowel surgery) (c-statistic 0.699-0.740).

    Humansemergency bowel surgeryn = 1,508

  3. Hospital Frailty Risk score predicts 30-day mortality in humans (OR 2.16).

    Humans

  4. Hospital Frailty Risk score predicts 30-day mortality in humans (undergoing elective noncardiac surgery) (AUC 0.87 vs 0.85).

    Humansundergoing elective noncardiac surgeryn = 171,576

  5. Hospital Frailty Risk score predicts 30-day mortality in humans (patients undergoing vascular surgery, high-risk frailty vs low-risk frailty) (OR 4.15, 95% CI 2.99 to 5.76).

    Humanspatients undergoing vascular surgery, high-risk frailty vs low-risk frailty

  6. Hospital Frailty Risk score is linked with a higher risk of 30-day mortality in humans (aOR 4.0 (95% CI 3.7-4.3) postdischarge; aOR 3.6 (95% CI 3.4-3.8) postadmission).

    Humansacute myocardial infarction hospitalization, HFRS >15 vs <5, adjusted for age, sex, race, and comorbidities

30-day readmission

upin humans5OR 1.27–1.67

5 studies
  1. Hospital Frailty Risk score is linked with a higher risk of 30-day readmission in humans after Impella mechanical circulatory support (OR 1.27, 95% CI 1.17-1.37).

    Humansafter Impella mechanical circulatory support30 daysn = 16,289

  2. Hospital Frailty Risk score is linked with a higher risk of 30-day readmission in humans (12.59% vs. 8.2%, OR 1.67, 95% CI 1.64-1.71, p < 0.001).

    Humansn = 885,416

  3. Hospital Frailty Risk score is linked with a higher risk of 30-day readmission in humans (critically ill patients receiving mechanical ventilation) (aOR 1.20, 95% CI 1.13-1.27).

    Humanscritically ill patients receiving mechanical ventilationn = 649,330

  4. Hospital Frailty Risk score is linked with a higher risk of 30-day readmission in humans (acute myocardial infarction hospitalization, HFRS >15 vs <5) (aOR 3.0, 95% CI 2.9-3.1).

    Humansacute myocardial infarction hospitalization, HFRS >15 vs <5

  5. Hospital Frailty Risk score predicts 30-day readmission in humans (OR 1.48, 95% CI 1.46-1.50).

    Humans

Inpatient mortality

upin humans4OR 5.5

4 studies
  1. Hospital Frailty Risk score is associated with inpatient mortality in patients with primary pulmonary hypertension (OR 5.5 (95% CI: 3.7-8.3), p < 0.001).

    Humansin patients with primary pulmonary hypertensionn = 4,555

  2. Hospital Frailty Risk score predicts inpatient mortality in humans (ERCP-related hospitalizations) (aOR 4.81, 95% CI: 3.77-6.14).

    HumansERCP-related hospitalizations

  3. Hospital Frailty Risk score is associated with inpatient mortality in humans (hospitalized adults with systemic lupus erythematosus).

    Humanshospitalized adults with systemic lupus erythematosuseight monthsn = 39,738

  4. Hospital Frailty Risk score is associated with inpatient mortality in humans (cirrhosis hospitalisations) (from 0.6 to 16.4%).

    Humanscirrhosis hospitalisationsn = 626,553

  5. Hospital Frailty Risk score predicts inpatient mortality in humans (cirrhosis hospitalisations) (AUC 0.782 vs. ECI 0.689, CCI 0.695, CirCom 0.692).

    Humanscirrhosis hospitalisationsn = 626,553

Length of hospital stay

upin humans4OR 2.89

4 studies
  1. Hospital Frailty Risk score is associated with length of hospital stay in humans after adjusting for age and gender (aOR 1.20, 95% CI 1.18-1.21).

    Humansafter adjusting for age and gender

  2. Hospital Frailty Risk score is associated with length of hospital stay in humans (major head and neck cancer surgery) (8.2 vs 6.8 days, P = .02).

    Humansmajor head and neck cancer surgeryn = 14,420

  3. Hospital Frailty Risk score predicts length of hospital stay in humans (hospitalized with COVID-19) (OR 2.89, 95% CI 1.53-5.44).

    Humanshospitalized with COVID-19

  4. Hospital Frailty Risk score predicts length of hospital stay in humans (higher risk group patients).

    Humanshigher risk group patientsn = 4,957

Major bleeding

upin humans3OR 1.82–6.18

3 studies
  1. Hospital Frailty Risk score is associated with major bleeding in humans (Cardiogenic shock treated with VA-ECMO; HFRS ≥5 versus <5) (Adjusted OR 1.82; p<0.001).

    HumansCardiogenic shock treated with VA-ECMO; HFRS ≥5 versus <5During hospitalizationn = 34,260

    Higher frailty linked to hospital deaths on heart-lung support

    AHA Scientific Sessions 2026 abstract
  2. Hospital Frailty Risk score is associated with major bleeding in humans (acute pulmonary embolism; high versus low HFRS) (aOR 7.65, 95% CI 6.68–8.76).

    Humansacute pulmonary embolism; high versus low HFRSduring hospitalizationn = 220,455

  3. Hospital Frailty Risk score is associated with major bleeding in humans (cardiogenic shock) (OR 6.18, 95% CI 5.53-6.92).

    Humanscardiogenic shockn = 640,595

More on Major bleeding

Hospitalization for influenza or pneumonia

upin humans1RR 2.8

1 study
  1. Hospital Frailty Risk score raises the risk of hospitalization for influenza or pneumonia in humans (intermediate vs low frailty risk) (RR 2.8 [95% CI 2.6-3.1]).

    Human trialintermediate vs low frailty risk

    High-dose flu vaccine may help more as frailty risk rises

    The lancet. Healthy longevity

Relative vaccine effectiveness

upin humans1

1 study
  1. Hospital Frailty Risk score is associated with relative vaccine effectiveness in humans (continuous Hospital Frailty Risk Score) (pinteraction=0·020).

    Human trialcontinuous Hospital Frailty Risk Score

    High-dose flu vaccine may help more as frailty risk rises

    The lancet. Healthy longevity
All 145

Latest

Dec 2025: 7Jan 2026: 5Feb 2026: 13Mar 2026: 3Apr 2026: 5May 2026: 6Jun 2026: 4Jul 2026: 5Aug 2026: 4Sep 2026: 7Oct 2026: 11Nov 2026: 878 papers in 12 months
International Wound Journal

Frailty alters link between blood-flow procedures and amputation

The adjusted odds ratio for major amputation with versus without blood-flow procedures was 0.30 with low frailty and 1.05 with high frailty.The adjusted odds ratio for major amputation with versus without blood-flow procedures was 0.30 with low frailty and 1.05 with high frailty.

Cohort · 2,588,159 peoplePopulations
AHA Scientific Sessions 2026 Abstract

Higher frailty linked to hospital deaths on heart-lung support

Deaths occurred in 49.3% of hospitalizations with high frailty scores versus 45.6% with low scores among adults on heart-lung support.Deaths occurred in 49.3% of hospitalizations with high frailty scores versus 45.6% with low scores among adults on heart-lung support.

Cohort · 34,260 peopleBiomarkers
AHA Scientific Sessions 2026 Abstract

Frailty linked to hospital harm in catheter mitral edge-to-edge repair

Adverse hospital events occurred in 33.0% of hospitalizations with frailty versus 5.1% without frailty for catheter-based mitral valve edge-to-edge repair.Adverse hospital events occurred in 33.0% of hospitalizations with frailty versus 5.1% without frailty for catheter-based mitral valve edge-to-edge repair.

Cohort · 60,165 peopleBiomarkers
Journal of Geriatric Oncology

Frailty linked to worse outcomes in chronic lymphocytic leukemia

Hospitalized adults with high frailty had 4.74 times the adjusted odds of dying in hospital compared with those with low frailty.Hospitalized adults with high frailty had 4.74 times the adjusted odds of dying in hospital compared with those with low frailty.

Cohort · 97,325 peopleChronic lymphocytic leukemia

See all 366 papers on Hospital Frailty Risk score